Rani Therapeutics Holdings, Inc. (RANI): Total Assets
$58.62M
As of 2025-12-31
$60.84M
As of 2026-06-30
-18.4%
3-year compound annual growth
-5.9%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.62M | +60.0% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $36.63M | -36.7% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $57.92M | -46.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $108.03M | -13.0% | 2024-03-20, Balance as of period end |
| 2021-12-31 | $124.21M | +56.4% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $79.42M | n/a | 2022-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $58.62M | +60.0% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $12.96M | +254.9% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $81.29M | +204.1% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $17.01M | -24.5% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $530.92M | +42.0% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
Compare RANI, NRXP, BIOE, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗